Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and approve the unaudited Financial ....
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics has informed the stock exchanges that its Board of Directors will meet on Wednesday, January 21, 2026. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company's trading window for insiders remains closed until January 23, 2026, as previously announced on December 27, 2025. This is a standard regulatory filing under SEBI LODR Regulation 29 ahead of the results announcement.
This is a routine procedural filing with no direct impact on the stock. Investors should watch the actual results on January 21 for performance details on revenue, margins, and profitability for Q3 FY26.